Cited by 35Sepsis Diagnosis and TreatmentInflammasome and immune disordersCardiac Ischemia and Reperfusion

Disulfiram inhibits oxidative stress and NLRP3 inflammasome activation to prevent LPS-induced cardiac injury

Wei, Shanshan, Xiao, Zijun, Huang, Jie, Peng, Zhenyu, Zhang, Bikui, Li, Wenqun·2022·International Immunopharmacology

Abstract

Sepsis-induced cardiac injury leads to the high rate of mortality, the therapeutics for this disorder are limited. Disulfiram (DSF) is an FDA-approved treatment for chronic alcohol addiction, and its cardio-protection is gradually discovered in recent years. In present study, mice were injected with lipopolysaccharide (LPS, 15 mg/kg) to induce a septic cardiac injury model, and aimed to investigate the protective effect of DSF on sepsis-induced cardiac injury and the underlying mechanisms. Results showed that DSF treatment alleviated the lowered left heart function and myocardial cell apoptosis induced by LPS. Moreover, we found that LPS increased myocardium lipid peroxidation, DNA damage and the activation of NLRP3 inflammasome, which were significantly reduced by DSF. These results suggested the protective role of DSF in LPS-induced cardiac injury, and the mechanism involved the inhibition on the oxidative stress and NLRP3 inflammasome activation. Given the potent cardiac protection effect of DSF, repurposing DSF in the clinic would represent a new strategy to protect and treat sepsis-induced cardiac injury.

Integrity signals

Registry

Crossref · 10.1016/j.intimp.2022.108545

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wei, S., Xiao, Z., Huang, J., Peng, Z., Zhang, B., & Li, W.
Affiliations
Central South University (CN)
Corresponding author
  • Zhang, Bikui
  • Li, Wenqun
Venue
International Immunopharmacology
Publisher
Elsevier BV
Published
2022-04
Volume
105
Pages
108545
ISSN
1567-5769 (ISSN-L)
OpenAlex
W4210277118
Cited by
35
References
28
Citations by year
2026: 6 · 2025: 7 · 2024: 6 · 2023: 11 · 2022: 5
FWCI
5.26
Type
journal article
Language
en
Open access
closed
Locations
  • International Immunopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Sepsis Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Cardiac Ischemia and Reperfusion
Keywords
disulfiram, lipopolysaccharide, NLRP3 inflammasome, oxidative stress, cardiomyocyte apoptosis, lipid peroxidation, DNA damage, drug repurposing, cardioprotection
MeSH terms
NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Disulfiram, Lipopolysaccharides, Oxidative Stress, Mice, Inflammasomes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review